MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

This cohort has 4,299,418 works, more than the 100,000-row export cap: the file will contain the first 100,000 ordered by OpenAlex id, and says so in its last line. Narrow the cohort, page the API, or rebuild the frame from the repository for the rest. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

4,299,418 results · 0 filters active
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
4,299,418 works in the cohort · of 4,299,418page 2,898 of 85,989

Labels cover 11,048 of 4,299,418 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 4,299,418 of 4,299,418 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundaboutno abstractunlabeled
Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study
Eric Winquist, Jennifer J. Knox, Jean-Pierre M. Ayoub, Nancy Wainman, Gregory K. Reid, Laura Pearce +2 more
2006· article· en· Investigational New Drugs· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
131
citations
affno abstractunlabeled
Widening the boundaries of the production effect
Noah D. Forrin, Colin M. MacLeod, Jason D. Ozubko
2012· article· en· Memory & Cognition· Neuroscience
machine prediction:candidate · noneconsensus · none
131
citations
affunlabeled
What is a Sports Injury?
Toomas Timpka, Jenny Jacobsson, Jerome Bickenbach, Caroline F. Finch, Joakim Ekberg, Lennart Nordenfelt
2014· article· en· Sports Medicine· Medicine
machine prediction:candidate · noneconsensus · none
131
citations
afffundno abstractunlabeled
Confidence and accuracy in deductive reasoning
Jody M. Shynkaruk, Valerie A. Thompson
2006· article· en· Memory & Cognition· Decision Sciences
machine prediction:candidate · noneconsensus · none
131
citations
affno abstractunlabeled
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age
Scott A. Halperin, Brian J. Ward, Curtis Cooper, Gerald Predy, Francisco Díaz‐Mitoma, Marc Dionne +11 more
2012· article· en· Vaccine· Medicine
machine prediction:candidate · noneconsensus · none
131
citations

How this was built: Screen · Findings · About